How We Support You

Built with the goal of radically transforming the rate of biomedical discovery and progress, Causaly’s AI reads the entire volume of biomedical literature ever published, in seconds. This makes it easy for anyone to run deep searches and find answers to complex research questions that would take weeks, or even months to discover with traditional keyword search. Zero in on the insights you need to make new hypotheses and discoveries.

Anyone can use Causaly. No semantic search knowledge is required.

We help pharmaceutical leaders, consumer goods manufacturers, bench scientists, life science investors, regulators, clinical librarians, market access consultants, academic researchers and others to accelerate scientific discovery and research.

Our Partners & Investors

Index Ventures logo
Pentech logo
EBRD Venture Capital Investment Programme logo
Marathon Venture logo

Our Founders

  • Yiannis Kiachopoulos

    Co-founder & CEO

    Yiannis is a computer scientist and has consulted with the world’s largest companies before co-founding Causaly in 2018. Yiannis holds a Bachelor and Master in Computer Science, an MBA from Hong Kong University of Science and Technology and took part in Singularity University’s Future Studies program.

  • Artur Saudabayev

    Co-founder & CTO

    Artur is a computer scientist and intelligent systems expert, with a background in machine learning and bioinformatics. For 7 years Artur was working in academia on applications of machine learning for vision and language problems in Robotics. Soon after attending Singularity University Future Studies and getting his Master degree in the University of Edinburgh, Artur taught his last course and started building Causaly with Yiannis.